BIOCRAFT AMILORIDE/HYDROCHLOROTHIAZIDE LAUNCH BOOSTS SALES AND EARNINGS "SIGNIFICANTLY"; CEFADROXIL ADDS TO NEARLY 50% SALES HIKE IN SECOND QUARTER

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".